Meeting Banner
Abstract #2472

Evaluation of Neoadjuvant Chemotherapy Response of Breast Cancer at 3.0T

Jeon-Hor Chen1,2, s Bahri1, P Carpenter3, H-J Yu1, R Mehta4, O Nalcioglu1, M-Y Lydia Su1

1Center for Functional Onco-Imaging, UC Irvine, Irvine, CA, United States; 2China Medical University Hospital, Taichung, Taiwan; 3Department of Pathology, UC Irvine, Irvine, CA, United States; 4Department of Medicine, UC Irvine, Irvine, CA, United States

The results analyzed from 3.0 T were consistent with our previous findings using 1.5T with a lower spatial resolution, suggesting that the limitation of MRI in diagnosis of post-NAC cancer cannot be improved with a higher SNR or a higher spatial resolution. Our current protocol at 3.0 T still could not detect residual tumor presenting as scattered cells or small foci, which often occurs in non-mass-like lesions. These types of invasive cancer cells do not need angiogenesis to survive, and if so, they will not show contrast enhancements.